Im Hansol, Kim Taewon, Na Seunghee, Song In-Uk, Kim Seong-Hoon, Oh Yoon-Sang, Oh Juhee, Kim Woojun
Department of Neurology, The Catholic University of Korea, Incheon St. Mary's Hospital, Seoul, Korea.
Department of Neurology, The Catholic University of Korea, Uijeongbu St. Mary's Hospital, Seoul, Korea.
Encephalitis. 2023 Jan;3(1):7-14. doi: 10.47936/encephalitis.2022.00059. Epub 2022 Dec 14.
We evaluated the associations between serum complement levels and tuberculous meningitis (TBM), bacterial meningitis (BM), and viral meningitis (VM), as well as the association between serum complement levels and mortality in TBM.
Background information and blood/cerebrospinal fluid analysis results were collected from 2009 to 2019. Patients who had serum complement level data collected at admission and who were diagnosed with TBM (n = 97), BM (n = 31), or VM (n = 557) were enrolled.
Initial serum complement levels were significantly lower in the TBM group than the VM group in both the total population and the propensity score-matched population. In the TBM and VM groups, compared to patients with initial highest-quartile C4 level, patients in the lowest quartile (C4 < 24.3 mg/dL) had significantly greater odds of TBM diagnosis (odds ratio, 2.2; 95% confidence interval, 1.0-4.5; p = 0.038). In the TBM group, patients with the lowest-quartile C3 level (<96.9 mg/dL) experienced a significantly higher 90-day mortality rate compared to other TBM patients (hazard ratio, 19.0; 95% confidence interval, 2.1-167.4.5; p = 0.008).
Both serum C3 and C4 levels were significantly lower in the TBM group than in the VM group. TBM patients with lower serum C3 level had a significantly higher mortality rate than those with higher C3 level.
我们评估了血清补体水平与结核性脑膜炎(TBM)、细菌性脑膜炎(BM)和病毒性脑膜炎(VM)之间的关联,以及血清补体水平与TBM死亡率之间的关联。
收集2009年至2019年的背景信息和血液/脑脊液分析结果。纳入入院时收集了血清补体水平数据且被诊断为TBM(n = 97)、BM(n = 31)或VM(n = 557)的患者。
在总体人群和倾向评分匹配人群中,TBM组的初始血清补体水平均显著低于VM组。在TBM和VM组中,与初始C4水平处于最高四分位数的患者相比,C4水平处于最低四分位数(C4 < 24.3 mg/dL)的患者被诊断为TBM的几率显著更高(优势比,2.2;95%置信区间,1.0 - 4.5;p = 0.038)。在TBM组中,C3水平处于最低四分位数(<96.9 mg/dL)的患者与其他TBM患者相比,90天死亡率显著更高(风险比,19.0;95%置信区间,2.1 - 167.4.5;p = 0.008)。
TBM组的血清C3和C4水平均显著低于VM组。血清C3水平较低的TBM患者死亡率显著高于C3水平较高的患者。